New Data From iRhythm Reinforce the Utility of Long-Term Amb

  Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations

Related Keywords

United States , Johns Hopkins , Gaurav Das , Mike Hsu , Kevinj Ferrick , Andrew Krumerman , Alext Sandhu , Mintu Turakhia , Alan Wilk , Martins Maron , Mintup Turakhia , Christopher Madias , Jayj Chudow , Lori Crosson , Krishna Pundi , Paula Heidenreich , Barryj Maron , Ardit Kacorri , Rhythm Technologies Inc , Va Health Care System , Heart Rhythm Society , University Of Rochester , Veterans Health Administration , Rhythm Technologies , Heart Rhythm , New Orleans , Enhances Identification , Higher Risk Patients With Hypertrophic , Premature Ventricular Complexes , Assessing Burden Density , Large National Cohort Population , Better Define Optimal , Practice Variation After Ambulatory , Non Sustained Ventricular Tachycardia , Care System , Randomized Placebo Controlled Trial , Patients With Arrhythmogenic Right Ventricular , Ventricular Complexes , Luigi Di Biase , Variation After Ambulatory , Jun Fan , Natasha Din , Placebo Controlled Trial ,